Davide Danovi from Progenitorlabs, spoke last week at the World Stem Cells & Regenerative Medicine Congress about the promise of identifying and targeting cancer stem cells to discover new treatments starting with the proposition that, because patients are unique, new techniques are required.
Key point raised on his presentations:
- Targeting critical pathways involved in cancer stem cell biology
- Development of poignant in vitro and in vivo assays for drug discovery purposes
- Characterisation of new therapeutic agents targeting vital cancer stem cell pathways
Check back here in a couple of days for the full presentation.